$IBIO
iBio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
IBIO chart
What traders are saying about $IBIO
Latest postsiBio, Inc. news
- iBio, Inc. (0JV.DE) Analyst Insights, Price Targets & Recommendations - Yahoo Finance
Yahoo! Finance Canada ·
- iBio, Inc. Estimates – NASDAQ:IBIO
TradingView ·
- iBio, Inc. (NASDAQ:IBIO) Stock Has Average Price Target of $6.00 According to Analysts
MarketBeat ·
- BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2027
Yahoo Finance ·
- iBio Shareholders Approve Governance and Capital Structure Changes
The Globe and Mail ·
- iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy
Yahoo Finance ·
- iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
Yahoo Finance ·
- iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
Yahoo Finance ·
- iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer
Yahoo Finance ·
- iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study
Yahoo Finance ·
- Could iBio (IBIO) Be an Underrated Obesity Stock?
Yahoo Finance ·
- iBio to Participate in Upcoming Healthcare Investor Conferences
Yahoo Finance ·
iBio, Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $100,000 | $400,000 | $225,000 | $0 |
| Net income | -$32.8M | -$18.4M | -$24.9M | -$65.0M |
| Diluted EPS | $-0.32 | $-1.75 | $-6.50 | $-106.19 |
| Total assets (year end) | – | $64.4M | $21.7M | $34.0M |
| Cash and equivalents (year end) | – | $28.7M | $7.0M | $2.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About iBio, Inc.
- Ticker
- IBIO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- June 30
- SEC CIK
- 1420720
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
Frequently asked questions
What exchange is iBio, Inc. listed on?
iBio, Inc. trades on the Nasdaq under the ticker symbol IBIO.
What industry is iBio, Inc. in?
iBio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is iBio, Inc. headquartered?
iBio, Inc.'s business address on file with the SEC is in New York, NY.
When does iBio, Inc.'s fiscal year end?
iBio, Inc.'s fiscal year ends on June 30.
How much revenue did iBio, Inc. report?
iBio, Inc. reported $100,000 in revenue for calendar year 2026, according to its SEC filings.